Style | Citing Format |
---|---|
MLA | Farhood B, et al.. "Disruption of the Redox Balance With Either Oxidative or Anti-Oxidative Overloading As a Promising Target for Cancer Therapy." Journal of Cellular Biochemistry, vol. 120, no. 1, 2019, pp. 71-76. |
APA | Farhood B, Najafi M, Salehi E, Hashemi Goradel N, Nashtaei MS, Khanlarkhani N, Mortezaee K (2019). Disruption of the Redox Balance With Either Oxidative or Anti-Oxidative Overloading As a Promising Target for Cancer Therapy. Journal of Cellular Biochemistry, 120(1), 71-76. |
Chicago | Farhood B, Najafi M, Salehi E, Hashemi Goradel N, Nashtaei MS, Khanlarkhani N, Mortezaee K. "Disruption of the Redox Balance With Either Oxidative or Anti-Oxidative Overloading As a Promising Target for Cancer Therapy." Journal of Cellular Biochemistry 120, no. 1 (2019): 71-76. |
Harvard | Farhood B et al. (2019) 'Disruption of the Redox Balance With Either Oxidative or Anti-Oxidative Overloading As a Promising Target for Cancer Therapy', Journal of Cellular Biochemistry, 120(1), pp. 71-76. |
Vancouver | Farhood B, Najafi M, Salehi E, Hashemi Goradel N, Nashtaei MS, Khanlarkhani N, et al.. Disruption of the Redox Balance With Either Oxidative or Anti-Oxidative Overloading As a Promising Target for Cancer Therapy. Journal of Cellular Biochemistry. 2019;120(1):71-76. |
BibTex | @article{ author = {Farhood B and Najafi M and Salehi E and Hashemi Goradel N and Nashtaei MS and Khanlarkhani N and Mortezaee K}, title = {Disruption of the Redox Balance With Either Oxidative or Anti-Oxidative Overloading As a Promising Target for Cancer Therapy}, journal = {Journal of Cellular Biochemistry}, volume = {120}, number = {1}, pages = {71-76}, year = {2019} } |
RIS | TY - JOUR AU - Farhood B AU - Najafi M AU - Salehi E AU - Hashemi Goradel N AU - Nashtaei MS AU - Khanlarkhani N AU - Mortezaee K TI - Disruption of the Redox Balance With Either Oxidative or Anti-Oxidative Overloading As a Promising Target for Cancer Therapy JO - Journal of Cellular Biochemistry VL - 120 IS - 1 SP - 71 EP - 76 PY - 2019 ER - |